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INTRODUCTION   
Starch is one of the most abundant and renewable 
biopolymers, which is very promising raw material, 
available at low cost for preparing various functional 
polymers. It is usually modified either physically, 
enzymatically or chemically to augment its convenience 
for industrial use.Physical modification involves the 
treatment of starch by physical means such as shear force, 
blending and thermal treatment
1
. Enzymatic modification 
usually involves hydrolysis and transglycosylation by 
carbohydrate enzymes
2
 and chemical modification is used 
to introduce desirable properties to starch for specific 
applications based on reaction of the free hydroxyl groups 
of the anhydrous glucose units (AGU) with functional 
groups of chemicals, resulting in starch 
derivatives
3
.Chemical modification is generally achieved 
through derivatization such as etherification, esterification, 
cross-linking and dual modification of starch, oxidation, 
dextrinization, acid-thinning or hydrolysis
1
.  
Carboxymethylation is a well-knownderivatization process 
for polysaccharides, resulting in polyelectrolytes
4
. 
Carboxymethyl starch (CMS) has unique properties due to 
the presence of negatively charged functional group 
(CH2COO-) and is officially listed in the United States 
Pharmacopoeia (USP) and the British Pharmacopoeia 
(BP)
5,6
.Carboxymethylation involves a two-step reaction: 
the first step is the alkalization of starch and in the second 
step, etherification occurs
7,8
. 
Enset(Enseteventricosum(Welw.)Cheeseman) and cassava 
(ManihotesculentaCrantz.) which belong to the family 
Musaceae and Euphorbiaceae, respectively are starch-rich 
staple foods widely used in the southern and south-western 
regions of Ethiopia
9,10
. The application of native starch as 
pharmaceutical gelling agent has been reported but 
discouraging mainly because of the need for a high 
concentration and heating to obtain viscous gel, the opacity 
of the formed gel, and its poor stability compared to other 
gelling agents
11
. Several reports indicate that 
carboxymethylation improves aqueous dispersibility and 
cold storage stability of starch pastes
12,13
.These improved 
properties suggest the potential application of CMS as a 
pharmaceutical gelling agent. Thus, the aim of the present 
work was to prepare and evaluatecarboxymethylEnsetand 
cassava starches as potential pharmaceutical gelling agents 
for topical applications. 
MATERIALS AND METHODS 
Materials 
Plant materials 
Boullawas purchased from the local Enset cultivating 
farmers in Durame, KambataTembaro Zone, South 
Nations Nationalities People Region (SNNPR), Ethiopia 
and cassava tubers were obtained from local cassava 
cultivating farmers in Sawula, GamoGofa Zone, SNNPR, 
Ethiopia. 
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Chemicals and solvents 
Monochloroacetic acid (MCA) (Hopkin& Williams Ltd, 
England) was obtained from Ethiopian Conformity 
Assessment Enterprise (ECAE). Triethanolamine (Fischer 
Chem Alert Guide, USA), sodium metabisulphite and 
hydrochloric acid (Guangzhou Jinhaunda Chemical 
Reagent Co. Ltd, China), isopropyl alcohol and glacial 
acetic acid (Riedel-de Haėn, Germany), methanol 
(ScharlauChemie SA, European Union), potassium 
dihydrogen phosphate (Sörensen, Leuren, Denmark), 
disodium hydrogen phosphate (Fizmerk chemicals, India), 
sodium hydroxide pellets (UNI-CHEM
®
 chemical reagent, 
China), ethanol (Joseph Mills (Denaturants) Ltd, Liverpool, 
England), sodium chloride (Oxford Laboratory, Mumbai, 
India), and formalin (BDH Chemicals Ltd, England) were 
all used as received.  
Active pharmaceutical ingredients and excipients 
Ibuprofen raw material powder and its working standard 
(Satwik Drugs Limited, India), sodium 
carboxymethylcellulose(FMC Corporation, USA) and 
propylene glycol (Research-lab fine Chem. Industries, 
India) were kindly supplied by Cadila Pharmaceuticals Sh. 
Co., Ethiopia.  Indomethacin and carrageenan (Sigma 
Chemical Co., USA) were obtained from Department of 
Pharmaceutical Chemistry and Pharmacognosy, School of 
Pharmacy, Addis Ababa University and Drug Research 
Directorate, Ethiopian Health and Nutrition Research 
Institute (EHNRI), respectively. Methyl parabenand propyl 
paraben (BDH Chemicals Ltd, England) were donated 
from the Ethiopian Pharmaceuticals Manufacturing Sh. Co. 
(EPHARM Sh. Co). All the materials were used as 
received. 
Test animals 
Mice of either sex (30-45 g) used in anti-inflammatory 
study were obtained from the animal houses at the School 
of Pharmacy and Department of Biology, Addis Ababa 
University, respectively. 
Methods 
Enset starch isolation 
Starch from boulla was isolated according to the method 
described byGebre-Mariam and Schmidt
9
.  
Cassava starch extraction 
Starch from cassava tubers was extracted using the method 
described elsewhere by Da etal
14
. 
Preparation of carboxymethylEnset and cassava 
starches 
Carboxymethylenset starch (CMES) and carboxymethyl 
cassava starch (CMCS) were prepared according to the 
procedure described by Jieet al
15
with slight modification. 
Briefly, 764 ml of organic solvent either isopropanol 
(ISPA) or methanol, was first mixed with water to a total 
volume of about 955 ml. Subsequently, 250 g Enset or 
cassava starch, which had already been dried in an oven 
(Kottermann
®
 2711, Germany) at 50 °C for 24 h, was 
added to a glass jacketed batch reactor with four necked 
stoppers fitted with a reflux condenser.The reaction 
medium was mixed in the glass reactor at room 
temperature. The reactor content was run at eight different 
reaction conditions (Table1). Then, 86.4 g NaOH in the 
form of pellets was added to the reaction mixture. After 15 
min, 51 g MCA powder was added to start the 
etherification reaction. A speed adjustable impeller (Ika-
Werke, guni, Hamburg, Germany) was used to stir the 
reaction medium. The stirrer speed was set at 250 rpm at 
the beginning of all reaction conditions but was reduced 
gradually. At the end, the reaction was stopped by 
neutralization with glacial acetic acid. The liquid 
supernatant was decanted and the product was washed 
several times with 80% methanol and finally with 
analytical grade methanol. The modified starch was finally 
dried in an oven (Kottermann
®
 2711, Germany) at 50 °C 
for 24 h, milled and passed through sieve size of 224 µm. 
Table 1: Reaction conditions used for carboxymethylation of Enset and cassava starches 
Reaction 
condition 
Starch source Reaction media 
(80%   v/v) 
Reaction temp.(°C) Reaction time 
(h) 
E-M-70-1 Enset Methanol 70 1 
C-M-70-1 Cassava Methanol 70 1 
E-I-70-1 Enset ISPA 70 1 
C-I-70-1 Cassava ISPA 70 1 
E-I-70-0.5 Enset ISPA 70 0.5 
C-I-70-0.5 Cassava ISPA 70 0.5 
E-I-50-1 Enset ISPA 50 1 
C-I-50-1 Cassava ISPA 50 1 
N.B.All reactions were conducted at starch/liquor ratio of 1:3; NaOH/reagent molar ratio of 4.0; and reagent/AGU molar ratio of 0.35. 
Determination of degree of substitution (DS) 
One gram CMS was converted to the H-form by treating 
with excess 0.1 N aqueous 80% methanolicHCl in a 100 
ml beaker with occasional stirring for 1 h. It was then 
filtered and washed several times with aqueous 80% 
methanol solution under suction in a sintered glass funnel 
(OAKTON
®
, WP-15-1, Japan),. The resulting sample was 
dried in an oven (Kottermann
®
2711, Germany) at 100 
o
C 
for 1 h and cooled in a desiccator. A portion of sample 
weighing 0.25 g was placed into a 250 ml conical flask and 
to this 100 ml DW was added, followed by 10 ml of 0.1 N 
NaOHsolution. The mixture was heated over a boiling 
water bath (GFL
®
, D3006, Germany) for 20 min until a 
clear solution resulted. The hot solution was then titrated 
with a standard 0.1 N HCl solution to a phenolphthalein 
end-point. Similarly processed native starch was used as a 
correction factor for the blank. Each sample analysis was 
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carried out in triplicate and the mean values were taken. 
The %Carboxyl and DS were calculated according to the 
method described byKhalil et al
16
 as shown in Eqn. 1and 2, 
respectively. 
 
          *
      
  ⁄ +                  
 Eqn. 1 
   
             
[                 ]⁄  
 Eqn. 2 
where,     (ml) is the volume of HCl used for the titration 
of the blank;  (ml) is volume of HCl used for titration of 
the sample;    -is weight in g of sample or native starch; 
and     -is molarity of NaOH. 
Preparation of polymer gels and drug formulations 
Polymer gels were prepared by a method described by 
Kittipongpatanaet al
11
by mixing the polymer powder at 
specified concentrations with distilled water (DW), and 
then allowing it to fully swell overnight before use.The 
modified starches, i.e., CMES and CMCS were prepared at 
concentrations of 6, 8 and 10% (w/w) and 8, 10 and 12% 
(w/w), respectively. Na-CMC was used at concentrations 
of 1, 2 and 3% (w/w) as commercial gelling agent. In 
addition, nine different medicated formulations (F1-F9) 
were prepared using the three polymers at the same 
concentrations as in the blank gels (Table 2). Briefly, the 
medicated gel formulations were prepared by weighing 2.5 
g of ibuprofen on an analytical balance (Mettler Toledo, 
PR 203, Switzerland) and dissolving it in a co-solvent of 
ethanol and propylene glycol (PG) (solution A). The 
preservatives, methyl paraben (MP) and propyl paraben 
(PP), were also dissolved in solution A. The respective 
polymers were allowed to swell fully overnight in half 
portion of the water. Solution A was added into the 
polymer gel under continuous stirring to yield a 
homogenous dispersion, which in turn was neutralized 
with triethanolamine (TEA) to obtain a colorless gel. The 
weight of the formulation was finally adjusted to final 
weight of 50 g by adding DW. 
 
 
Table 2:Percentage composition (w/w) of the different ibuprofen gel formulations 
Formula Ibuprofen CMES CMCS Na- CMC Ethanol PG TEA MP PP DW(qs) 
F1 5 6 - - 10 10 3 0.135 0.027 100 
F2 5 8 - - 10 10 3 0.135 0.027 100 
F3 5 10 - - 10 10 3 0.135 0.027 100 
F4 5 - 8 - 10 10 3 0.135 0.027 100 
F5 5 - 10 - 10 10 3 0.135 0.027 100 
F6 5 - 12 - 10 10 3 0.135 0.027 100 
F7 5 - - 1 10 10 3 0.135 0.027 100 
F8 5 - - 2 10 10 3 0.135 0.027 100 
F9 5 - - 3 10 10 3 0.135 0.027 100 
 
Physicochemical evaluation of the gels 
Visual appearance and cosmetic qualities.All prepared 
gels were physically inspected for clarity/transparency, 
color, odor, texture, consistency, and homogeneity after 
they have been filled intoglass jars. The prepared gels were 
also evaluated for the presence of particles or aggregates. 
pH.The pH of each gel formulation was measured using a 
pH meter (model PH-210, HANNA instruments, Portugal) 
which has been pre-calibrated with standard buffer 
solutions of pH 4, 7 and 10. The samples were in contact 
with the pH electrode until the reading stabilized. The 
electrode was thoroughly rinsed with DW between each 
determination to remove all traces of the sample. The 
averages of three readings wererecorded as pH values. 
Drug content determination.Specific quantity (100 mg) 
from each prepared gel was withdrawn at random from 
three different sampling points i.e., from the upper, middle 
and lower portionsof each batch and dissolved in 50 ml of 
phosphate buffer saline (PBS, pH 7.4) and 2.5 ml aliquot 
was diluted in 25 ml volumetric flask. The volumetric 
flask containing the gel solution was vigorously mixed to 
ensure homogenous dispersion of the formulation 
ingredients. This solution was filtered and the 
concentration was estimated spectrophotometrically at 221 
nm using pH 7.4 PBS as blank. The drug content was 
determined from standard calibration curve of ibuprofen in 
pH 7.4 PBS. 
 
Rheological studies.The viscosities of the gel 
formulationsat different concentrations were determined at 
room temperature by a rotational viscometer (Kinematica, 
AG, Type ViscostarPlus L, Switzerland) using different 
spindle numbers L1, L2, L3, and L4 at different shear rates: 
0.5, 1, 5, 10, 20, 30, 50, 60, 100 and 200 rpm. The gels 
were placed in the sample holder and the suitable spindle 
selected was carefully lowered perpendicularly into the 
sample such that the spindle does not touch the bottom of 
the container. The spindle was attached to the viscometer 
and then it was allowed to rotate at a defined speed at 
room temperature to obtain stable viscosity reading. 
Gel clarity. Gel clarity was determined by placing a 
sample of polymer gel or gel preparation in a disposable 
cuvette and measuring the absorbance at 700 nm using a 
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spectrophotometer (CECIL, 1021, 1000 series, England) 
against water as blank
11
. 
Spreadabilityof ibuprofen gel formulations.Concentric 
circles of different radii were drawn on graph paper and a 
400 cm
2
 glass plate was fixed onto it. Gel (1.0 g) was 
transferred to the centre of the lower plate and spread over 
a diameter of 2.4 cm. Another 400 cm
2
 glass plate of 185 g 
was placed gently on the gel and a standardized weight of 
170 g was allowed to rest on the upper glass plate for 3 
min. The increase in the diameter due to gel spreading was 
recorded
17
. 
Extrudability.The method adopted for evaluating gel 
formulation for extrudability was based on the quantity in 
percentage of gel extruded from tube on application of 
certain load. The formulation under study was filled in a 
clean, lacquered aluminum collapsible tube with a 
nozzletip of 5 mm opening. It was then placed between 
two glass slides and was clamped. Extrudability was 
determined by weighing the amount of gels extruded 
through the tip when a constant load of 1 Kg was placed 
on the slides. The percentage of gel extruded was 
calculated and grades were allotted (++++ excellent, if> 90% 
of gel extruded; +++ very good, if 80-89.9%; ++ good, if 
70-79.9%; + fair, if 50-69.9% and 0 poor, if<50% of gel 
extruded)
18
. 
In vitrodrug release study 
One gram gel sample of each formulation that corresponds 
to 50 mg of ibuprofen was carefully weighed and placed 
on cellulose acetate membrane (Sartorius, Goettingen, 
Germany) with an average pore size of 0.45 µm which was 
previously soaked in PBS (pH 7.4) for 60 min and fixed to 
one end and made water-tight with aid of rubber band in an 
apparatus consisting of cylindrical tube with both ends 
open, 100 mm in height, 12.9 mm outer diameter and 12.1 
mm  inner diameter (release area=115 mm
2
) as a diffusion 
cell. The tubes were submerged in a 1000-ml beaker 
containing 400 ml PBS (pH 7.4) as receptor medium and 
equipped with stirring and temperature-controlling devices. 
The whole assembly was fixed insuch a way that the lower 
end of the cell containing the gel just touched (1-2 mm 
deep) the diffusion medium.The release test was carried 
out at a controlled stirring rate of 100 rpm to ensure sink 
condition and a temperature of 37 ± 1 °C by means of 
water jacket surrounding each cell. At 5, 15, 30, 60, 120, 
180, 240, 300, 360, 480, 600 and 720 min, 5 ml of the 
buffer containing the released ibuprofen was withdrawn 
from the beaker and replenished by the same volume of 
fresh buffer at 37 ± 1 °C to maintain constant volume. The 
withdrawn sample was diluted to an appropriate volume 
and the absorbance was measured spectrophotometrically 
at 221 nm and the amount of ibuprofen released from the 
gel formulations was calculated based on the established 
standard calibration curve. Each sample was tested six 
times and mean values were taken
19
. 
Kinetics and mechanism of drug release 
To analyze the mechanism of drug release from the gel 
preparations, the release data were fitted to the following 
equations
20
:  
i. Zero – order equation: 
                   Eqn. 3 
where,    is the amount of drug present initially,   is the 
amount of drug remaining at time t, and    is the zero – 
order release rate.  
ii. First – order equation:  
                 Eqn. 4 
where,    is the amount of drug present initially,   is the 
amount of drug remaining at time t, and   is the first – 
order release rate constant.  
iii. Higuchi’s equation:  
     √             Eqn. 5 
where,   is the amount of drug released per unit area at 
time  (mg cm
-2
),  is the time after the application (sec),    
is the initial drug concentration in the donor chamber (mg 
cm
-3
),   is a constant and      is the apparent diffusion 
coefficient (cm
2 
sec
-1
);      is calculated from the slope  
(apparent release rate) of the linear plot of   versus t1/2; 
hence, 
     
   
   
 ⁄          Eqn. 6 
Anti-inflammatory activity study 
Anti-inflammatory activity of the medicated gel 
formulations was performed using carrageenan-induced 
paw edema method. The mice of either sex weighing 30-
45 g were fasted overnight, but water was allowed ad 
libitum. The animals were divided into six groups of five 
animals each. Group 1-3 (control) received non-medicated 
polymer gels prepared from 8% (w/w) CMES, 10% (w/w) 
CMCS, and 2% (w/w) Na-CMC by gently rubbing the gels 
on the plantar surface of the left hind paw;similarly, 
groups 4, 5 and 6 (test) received 0.25 g of the medicated 
ibuprofen gel formulations prepared from the 
corresponding concentrations of the polymers (F2, F5 and 
F8, respectively). After 1 h, 0.05 ml of 1% (w/w) 
suspension of carrageenan was injected into the left plantar 
surface of the hind paw of all groups using a syringe with 
needle (Shandong Zibo Shacchuan Medical Instrument Co., 
Ltd., China). The hind paw volume was measured at 
different time intervals for 5 h after carrageenan treatment 
using a plethysmometer(UGO BASILE, 7140, Italy). The 
percent inhibition in hind paw edema volume was 
calculated using the formula shown in Eqn. 7 and 
compared with those recorded for the control group. 
                   (  
  
  
⁄ )           Eqn. 7 
where,   ‐is mean edema volume of test,   ‐is mean edema 
volume of control
21
. 
Stability studies 
Stability studies on selected formulations were carried out 
at different conditions, i.e., real time stability conditions 
(25 
o
C/60% RH), at accelerated conditions (40 
o
C/75% RH) 
in stability chamber (Binder 
®
, England) and in refrigerator 
(LG, South Korea) at 4 
o
Cfor 3 months. The gel 
formulations were then observed for different evaluation 
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parameters such as change in the consistency, color, odor, 
pH, drug contents and phase separation or syneresis and 
compared with the initial formulations stored at room 
temperature
22
. 
Statistical analysis 
All data reported in this study are averages of triplicate 
determinations except for the in vitro drug release study 
(n= 6) and anti-inflammatory activity study (n= 5). 
Wherever appropriate, the data were subjected to statistical 
analysis using Instat +, V. 3.33 (Statistical Services Centre, 
The University of Reading, UK) and Origin®, version 7.0 
SR0 (OriginLab Corporation, MA, USA) assisted by MS 
Excel 2007. In all cases, individual differences between in 
vitro drug release profile, viscosity of gels, anti-
inflammatory study data and all other relevant data were 
evaluated using a Tukey's test for one-way analysis of 
variance (ANOVA).  P value of less than 0.05 was 
considered to be evidence for a significant difference. 
Results and discussion 
Factors affecting degree of substitution  
The DS is defined as the average number of substituents 
per AGU, the monomer unit of starch which indicates the 
amount of carboxymethyl group formed. Since each AGU 
contains three hydroxyl groups at carbon numbers 2, 3, and 
6, the DS lies between zero and three
4,8
.Under the same 
conditions of carboxymethylation, the DS values of the 
CMS obtained from Enset starch were higher than those of 
the CMS obtained from cassava starch at all reaction 
conditions investigated indicating that origin influences the 
DS (Table 3). Highest DS (0.926) was obtained for the 
Enset starch when the reactor content was run at 70 °C for 
1 h using ISPA as reaction medium (E-I-70-1); on the 
other hand, the least DS (0.158) was obtained for cassava 
starch in methanol as reaction medium at the same reaction 
condition (C-M-70-1).  
 
Table 3: Effects of starch source, solvent media, reaction temperature and time on DS 
Reaction condition Product behavior 10 min 
before removal from the 
reactor 
% Carboxyl (mean 
± SD) 
DS            (mean 
± SD) 
Properties of 6% CMS  
in water 
E-M-70-1 Slightly stirrable 6.51 ± 0.180 0.255 ± 0.008 Slightly turbid and  gel 
particles 
C-M-70-1 Easily mixed and 
stirred 
4.14 ± 0.360 0.158 ± 0.015 Paste/dispersion 
E-I-70-1 Strong gummy product; 
not mixed 
19.32 ± 0.453 0.926 ± 0.029 Stiff gel 
C-I-70-1 Gummy product; not stirrable 16.90 ± 1.803 0.778 ± 0.010 Flowable gel 
E-I-70-0.5 Product very firm; 
slightly mixed 
11.03± 0.231 0.463 ± 0.017 Thin flowable  gel 
C-I-70-0.5 Product moderately firm; 
slightly mixed 
9.74± 0.172 0.401 ± 0.008 Thin flowable  gel 
E-I-50-1 Product less firm; 
not easily mixed 
6.86± 0.197 0.271 ± 0.001 Weak and easily 
flowable  gel 
C-I-50-1 Product less firm; 
less mixed 
5.26± 0.276 0.203 ± 0.021 Weak and easily 
flowable  gel 
 
It is well known that the structural and physicochemical 
characteristics of starches are related to their botanical 
sources. Starch characteristics such as amylose content, 
branch chain length distribution of amylopectin, phosphate 
monoester, phospholipids and lipid contents affect their 
functional properties. The granule shape and size also 
affect the functional properties of starches
23
. The reported 
amylose content of Enset starch is 29%
9
and that of cassava 
starch is 16.1%
10
. Moreover, Enset starch has been shown 
to have normal granule size distribution with a mean 
particle size of 46 µm with characteristic morphology of 
somewhat angular and elliptical
9
while that of cassava 
starch is 12.71 µm showing spherical morphology
10
.The 
large size differences between Enset and cassava starches 
indicate that the surface area of the latter starch granules is 
larger rendering more OH groups at the surface which may 
lead to higher DS. However, on the contrary, Enset starch 
has significantly larger proportion of amylose that 
contributes to higher rate and extent of reaction and hence 
DS. 
The choice of organic solvent also had a significant 
influence on DS (Table 3).This could be due to the high 
ability of ISPA to dissolve the etherifying agent and 
enhance starch swelling and viscosity when compared to 
methanol. Moreover, an increase in temperature enhances 
solubility of the etherifying agent and facilitates both the 
swelling of the starch molecules and the diffusion of the 
reactants. The CMS which were prepared using ISPA 
formed gel and then gummy mass, making stirring difficult; 
and it was also difficult to remove the products. These 
observations are consistent with the report of Lawalet 
al
4
on carboxymethylcocoyam starch at higher temperatures. 
So, depending upon the DS and rheological properties, 
modified Enset and cassava starches obtained using 
reaction conditions E-I-70-1 and C-I-70-1were employed 
as gelling agents in subsequent investigations and 
designated as CMES and CMCS, respectively. 
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Physicochemical evaluation of gel formulations 
Nine different gel formulations of ibuprofen were prepared 
using CMES, CMCS and Na-CMC as gelling agents. The 
physicochemical properties of the gel formulations are 
shown in Table 4. All the prepared gel formulations shared 
good and smooth homogeneous appearance, and pleasant 
smell which was attributed to the presence of alcohol in 
the formulations. The ibuprofen gel formulations spread 
smoothly on a clean even glass plate with minimum 
pressure without any solid or gritty particles. Furthermore, 
the physical appearance of the gel formulations F7, F8 and 
F9 were transparent while formulations of the modified 
starches (F1-F6) were translucent.  
The pH values of the gel formulations ranged from 
6.80±0.02-7.22±0.06 (n=3), within physiologically 
acceptable pH and, in principle, were devoid of any skin 
irritation
20,24,25
.The uniform distribution of drug was 
confirmed by content uniformity studies. As depicted in 
Table 4, the ibuprofencontent in all gel formulations was 
found to range from 98.76±0.21-100.2±0.42% (n=3) of the 
theoretical value of 5%, w/w which is within the 
acceptable limits (95.0 to 105.0%)
6
and ensured the 
uniformity of the drug content in the formulations. 
Based on visual observation and absorbance 
measurementat 700 nm, the clarity of the medicated CMS 
preparations was found to be much better than those of the 
corresponding polymer gels as depicted in Table 4. This 
could be due to the incorporation of TEA in the medicated 
gel formulations. TEA was incorporated to adjust the pH 
and to increase the solubility of the drug in the gel 
formulations
26,27
. However, it appears that TEA also has 
additional solubilizing effect on the polymer gel matrix. 
Formulations without TEA produced gels that were 
whitish cream with simultaneous precipitation of the drug 
as fine grit dispersions indicating the presence of chemical 
incompatibility due to pH variation. Further, it was 
observed that the absorbance readings of the gel 
formulations increased significantly with increasing 
concentration of the polymers showing that gel clarity was 
influenced by concentration and nature of polymer with 
the rank order of  Na-CMC> CMES> CMCS. 
The vehicle also plays a key role in the appearance, feel, 
and successful application of the topical 
preparations
28
.Clear or translucent homogenous gels are 
often preferred by consumers. Increasing the ethanol 
content in all formulations precipitated the CMS and Na-
CMC that led to the formation of two distinct phases, i.e., a 
clear solution and semi-solid layer. 
 
Table 4: Physicochemical properties of the different ibuprofen gel formulations 
Formula Physical 
appearance 
Ibuprofen 
Content (%)  
pH 
 
Extrud- 
ability 
Spreading 
diameter 
(mm) 
     Absorbance at 700 nm 
Polymer gelFormulation 
F1 Translucent 100.2 ± 0.42 7.17 ± 0.09 +++ 88.16 ± 1.73 0.323 ± 0.009 0.203 ± 0.016 
F2 Translucent 98.96 ± 0.12 7.21 ± 0.01 ++ 71.43 ± 1.73 0.386 ± 0.004 0.227 ± 0.006 
F3 Translucent 99.32 ± 0.64 7.22 ± 0.06 + 53.98 ± 1.16 0.408 ± 0.003 0.301 ± 0.015 
F4 Translucent 99.95 ± 0.53 6.86 ± 0.02 ++ 79.51 ± 0.58 0.456 ± 0.029 0.346 ± 0.009 
F5 Translucent 99.81 ± 0.21 6.80 ± 0.02 + 69.32 ± 1.16 0.591 ± 0.019 0.421 ± 0.019 
F6 Translucent 98.89 ± 0.49 6.83 ± 0.03 + 56.40 ± 0.58 0.718 ± 0.004 0.568 ± 0.014 
F7 Transparent 99.95 ± 0.74 7.01 ± 0.02 +++ 87.05 ± 1.16 0.018 ± 0.002 0.017 ± 0.000 
F8 Transparent 99.60 ± 0.21 6.98 ± 0.09 ++ 70.23 ± 1.73 0.022 ± 0.001 0.021 ± 0.000 
F9 Transparent 98.76 ± 0.21 7.19 ± 0.09 + 55.74 ± 2.31 0.025 ± 0.001 0.024 ± 0.000 
N.B. numerical results are given as mean±SD; +++ very good, ++ good,  + fair 
The increase in diameter of ibuprofen gel formulations 
following the spreadability test was found to range from 
53.98±1.16 –88.16±1.73 mm (n=3). As the concentration 
of the polymer increased, the spreadability of the 
formulation decreased. As depicted in Table 4, F1, F4 and 
F7 showed the highest spreadability among the respective 
polymers: CMES, CMCS and Na-CMC depending upon 
the concentration of the polymers. Spreading of topically 
applied products affect drug delivery as reflected by 
dermatopharmacokineticstudies
26
. Formulations with 
higher spreadability values allow ease of application and 
thereby increased surface area available for drug 
permeation. A good gel takes less time to spread and will 
have high spreadability
29,30
. 
Viscosity is an important physical parameter for 
characterizing gels as it affects the extrudability, 
spreadability, release of drug and other physicochemical 
properties
21
.As shown in Fig. 1, the gel formulations 
showed decreasing viscosity with increased shear rate from 
0.5 to 200 rpm exhibiting a shear-thinning behavior. 
Moreover, ibuprofen gels prepared from CMES had 
significantly higher viscosity values than those of CMCS, 
both set of formulations exhibiting increased viscosity with 
increasing polymer concentration. 
The apparent viscosity values of the CMS gels were found 
to be significantly higher when compared with the 
corresponding concentrations of the medicated 
formulations as depicted in Fig. 2.These results might be 
attributed to the relatively higher concentrations of ethanol 
and propylene glycol present in the medicated gel 
formulations that decrease the relative solubility and 
swellability of the polymers compared to the pure polymer 
gels
31
.  
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Figure 1: Plot of viscosity vs. shear rate for F1-F6 medicated gel formulations 
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Figure 2: Viscosities of (A) CMES gels and corresponding medicated gel formulations (F1, F2 and F3), and (B) CMCS 
gels and corresponding medicated gel formulations (F4, F5 and F6) at different shear rates at room temperature.  
In vitrodrug release from gel formulations 
Fig. 3 shows the release profile of ibuprofen from the nine 
gel formulations using synthetic cellulose acetate as 
diffusion membrane. The results show that as the 
concentration of CMES, CMCS and Na-CMC in the gel 
formulations increased from 6-10% (w/w), 8-12% (w/w) 
and 1-3% (w/w), the percent of ibuprofen released into the 
buffer medium gradually decreased from 84.5 to 
43.8 %/cm
2
, 77.6 to 50.6 %/cm
2
and 69.1 to 52.4 %/cm
2
, 
respectively. This decrease in the release is likely 
attributed to increased micro-viscosity, i.e., the 
environment through which the solute molecules travel as 
the polymer concentrations increase
32,33
. 
Ricci et al.(2005) reported that drug release from gels is 
controlled by gel dissolution and drug diffusion from the 
gel matrix
34
. In the diffusion process, there are believed be 
two steps: one is diffusion through the gel, and the other is 
diffusion through the membrane.The diffusion 
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measurements obtained are thus a combination of both 
these processes
35
. It is possible that at higher polymer 
concentrations, the active substance will be trapped in 
smaller polymer cells as it will be structured by its close 
proximity to the polymer molecules and this increases the 
diffusional resistance.Rheological properties are known to 
be related to the gel structure, inter-chain interactions, and 
polymer chain entanglements, which in turn affect drug 
release and diffusion processes
36,37
. Further, when the drug 
diffusion through the vehicle is a rate limiting step, the 
viscosity of vehicles may play an important role in 
controlling the drug release
38
. 
From the release profiles depicted in Fig. 3, it is observed 
that, initially (~1 h), drug was released rapidly (burst effect) 
followed by a slow release for the rest of the release study 
period. The initial burst effect could be due to the release 
of the drug to the surface of the immediate barrier 
membrane. Thus, the molecule that is easily accessible to 
the solvent at the interface immediately diffuses into the 
receiver compartment establishing a burst effect. As the 
time advances, there exist greater resistance to the 
penetration of the solvent to the inside of the gel matrix 
resulting in a slower release rate thereby exhibiting 
retarded and steady release profile.  
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Figure 3: Release profiles of ibuprofen from gel formulations through synthetic cellulose acetate membrane. 
Drug release kinetics 
The drug release data were fitted to zero order, first order 
and Higuchi kinetic models and analysed. The results show 
that the Higuchi kinetic model best fitted the 12 h release 
profile as confirmed by the highestcorrelation coefficients 
shown in Table 5. This finding indicates that the rate-
controlling mechanism in the drug release process is the 
diffusion of the dissolved drug through the vehicle 
network to the external medium, which is in agreement 
with other studies
20,28,39
. 
In addition, the drug diffusion coefficient (D) was found to 
be affected by polymer content and nature of the polymer 
used.The diffusion coefficient values calculated from the 
Higuchi plots for the different formulations were found to 
decrease inversely as a function of polymer concentration. 
The apparent release rate of ibuprofen from F1 (12.7 ± 
0.037 mg cm
-2 
h
-1/2
) is the largest of all the formulations 
and about 2.4 times higher than F3 which has the smallest 
release rate (5.4 ± 0.018 mg cm
-2 
h
-1/2
) (p<0.05). Drug 
release rate constant of F4 (11.6 ± 0.015 mg cm
-2 
h
-1/2
) is 
significantly higher when compared to F5 (9.1 ± 0.025 mg 
cm
-2 
h
-1/2
) and F6 (7.3 ± 0.021 mg cm
-2 
h
-1/2
) (p<0.05). 
These findings support the fact that the release rate is 
influenced by the rheological properties of the 
formulations as well as the nature of the polymer 
composing the vehicle.  
 
Table 5: Kinetic model fitting of thein vitro ibuprofen release profiles of the gel formulations. 
Formula R
2
 K (mg cm
-2 
h
-1/2
) (mean ± 
SD) 
(D, cm
2
 sec
-1
) x 10
-5 
(mean ± SD)
 
 
Zero-order First-order Higuchi   
F1  0.894 0.935 0.986 12.7 ± 0.037 1.48 ± 0.012  
F2  0.722 0.753 0.893 6.9 ± 0.047 0.44 ± 0.019  
F3  0.772 0.788 0.931 5.4 ± 0.018 0.25 ± 0.003  
F4  0.889 0.926 0.984 11.6 ± 0.015 1.23 ± 0.002  
F5  0.945 0.966 0.985 9.1 ± 0.025 0.75 ± 0.005  
F6  0.919 0.940 0.982 7.3 ± 0.021 0.46 ± 0.004  
F7  0.844 0.872 0.967 8.8 ± 0.031 0.72 ± 0.009  
F8  0.747 0.771 0.916 7.7 ±0.014 0.54 ± 0.002  
F9  0.758 0.782 0.921 7.1 ± 0.017 0.43 ± 0.003  
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Formulations F2, F5 and F8 were selected from the 
ninemedicated gel formulations for furtheranti-
inflammatory activity as well as stability studies on the 
basis of physicochemical parameters evaluation and their 
representativeness. 
Anti-inflammatory activity: 
In control groups which received carrageenan alone, rapid 
andcontinuous increase in paw volume (i.e., inflammation) 
was observed andthe inflammation was sustained during 
the entire period of study.The test products (F2, F5 and F8) 
exhibited anti-inflammatory activity up to 5 h (Fig. 4). The 
highest anti-inflammatory activity was obtained in F5 (78 
± 0.392%), followed by F8 (68 ± 0.459%), and then F2 (59 
± 0.415%) after the 5
th
h study. The variation of activities 
could partly be attributed to the variation in the rate and 
extent of drug release as discussed in the in vitro release 
study.As shown in Table 5, F5 had the highest drug release 
rate and diffusion coefficient which contributed to 
itshighest anti-inflammatory effect. 
Stability studies 
None of the selected ibuprofen gel formulations (F2, F5 
and F8) showed any appreciable change in gel clarity, 
physical appearance and homogeneity indicating physical 
stability when inspected at intervals of 1, 2, and 3 months 
as depicted in Table 6. Furthermore, no obnoxious odor 
was perceptible from any of the gel formulations. Even 
after exposure to heat and humidity, no significant change 
was observed in pH and drug content of the gel 
formulations. Besides, there was no appearance of air 
bubbles and crystals or precipitates during the stability 
study. Thus, all gel formulations were found to be stable 
under all storage conditions. 
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Figure4.Percent inhibitions of hind paw edemafollowing 
the application of ibuprofen gel formulations. 
 
Table 6: Physicochemicalproperties of ibuprofen gel formulations after 3 months storage under different conditions 
Formula Storage 
conditions 
Color change, 
precipitate 
formation 
Ibuprofen 
content (%) 
 
Physical 
appearance 
 
Homog- 
eneity 
     pH 
 25 ºC /60 % RH Nil 99.62 ± 0.53 Translucent Good 7.17 ± 0.02 
F2 40 ºC /75 % RH Nil 98.72 ± 0.34 Translucent Good 7.28 ± 0.01 
 4 ºC Nil 98.53 ± 0.67 Translucent Good 7.24 ± 0.06 
 25 ºC /60 % RH Nil 99.85 ± 0.37 Translucent Good 6.96 ± 0.04 
F5 40 ºC /75 % RH Nil 99.31 ± 0.51 Translucent Good 6.88 ± 0.03 
 4 ºC Nil 99.11 ± 0.47 Translucent Good 6.86 ± 0.02 
 25 ºC /60 % RH Nil 99.71 ± 0.52 Transparent Good 7.07 ± 0.05 
F8 40 ºC /75 % RH Nil 99.46 ± 0.37 Transparent Good 7.15 ± 0.09 
 4ºC Nil 98.58 ± 0.31 Transparent Good 7.11 ± 0.08 
 
CONCLUSIONS 
Carboxymethyl starches of Enset and cassava were 
prepared as a product of the reaction of starch and 
monochloroacetic acid in the presence of sodium 
hydroxide at different reaction conditions. Subsequently, 
nine topical gel formulations of ibuprofen were prepared 
based on the concentration and type of polymers as gelling 
agents using carboxymethylEnset starch (CMES), 
carboxymethyl cassava starch (CMCS) and sodium 
carboxymethylcellulose (Na-CMC).The results showed 
that carboxymethylation was significantly affected by the 
source of starch, reaction medium, reaction temperature as 
well as reaction time. Isopropyl alcohol offered a better 
medium for carboxymethylation compared to methanol. 
The drug release data of all gel formulations best fitted to 
Higuchi model when compared to zero order and first 
order kinetics following in vitro drug release studies over 
12 h. The in vitro drug release results indicated that the 
cumulative drug release, the apparent release rate, and the 
diffusion coefficient of ibuprofen were influenced not only 
by the rheological properties of the formulations but also 
by the nature of the polymers. The anti-inflammatory 
activities of the medicated gel formulations in mouse hind 
paw edema model revealed that ibuprofen was delivered to 
the inflammation site at adequate level to significantly 
lower inflammation induced by carrageenan injection. The 
medicated gels also showedexcellent stability profile for at 
least 3 months under different storage conditions. 
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